Losartan Market to Grow with a CAGR of 3.75% through 2030
Surge in research and development activities is
expected to drive the Global Losartan Market growth in the forecast period, 2026-2030.
According to TechSci Research report, “Losartan
Market - Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2030F”, the Global Losartan Market stood at USD 728.50
Million in 2024 and is anticipated to grow with a CAGR of 3.75% through 2030. Initiatives
taken by government based on losartan has led to favorable market conditions
for the Global Losartan Market. Several factors contribute to the growth of
various losartan products.
Pharmaceutical companies and academic institutions are
increasingly focusing on optimizing losartan’s pharmacological properties.
Research efforts are being directed toward developing novel drug delivery
systems, such as extended-release tablets, fixed-dose combinations, and orally
disintegrating formulations to enhance patient compliance, particularly among
the elderly and those with multiple comorbidities. These advancements help
improve dosing convenience, reduce side effects, and enhance therapeutic
outcomes.
One of the key government-driven strategies is the inclusion of Losartan in national essential medicines lists. By recognizing Losartan as a critical drug for the management of hypertension and associated cardiovascular conditions, governments ensure its availability through public healthcare systems and subsidized programs. This inclusion facilitates broader access, particularly in low- and middle-income countries, thereby expanding the drug’s market penetration. In addition, several public health campaigns and national screening programs for hypertension and cardiovascular diseases have been launched in recent years. These programs aim to improve early diagnosis and long-term management of chronic conditions, leading to increased demand for antihypertensive medications such as Losartan.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Losartan Market”
The Global Losartan Market is segmented into source, application,
regional distribution, and company.
Based on Source, In-House have emerged
as the dominating segment in the Global Losartan Market in 2024. This is primarily
due to the strategic advantages it offers in terms of quality control,
intellectual property protection, and operational oversight. Major
pharmaceutical companies producing Losartan are increasingly opting to retain
full control over the manufacturing process to ensure product consistency,
regulatory compliance, and brand reputation. One of the primary drivers behind
the dominance of in-house manufacturing is the ability to maintain stringent
quality standards.
Based on Region, Asia Pacific have emerged as the fastest
growing region in the Global Losartan Market in 2024. This is due to a
convergence of demographic, economic, and healthcare-related factors that are
accelerating demand for antihypertensive therapies. One of the primary drivers
is the region’s rapidly expanding population, particularly in countries such as
China and India, where there is a significant rise in the prevalence of
hypertension and cardiovascular diseases linked to urbanization, sedentary
lifestyles, and dietary changes.
Major companies operating in Global Losartan Market
are:
- Merck & Co. Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Novartis International AG
- Dr. Reddy's Laboratories Ltd.
- Sun Pharmaceuticals Industries Ltd.
- Aurobindo Pharma Ltd.
- Torrent Pharmaceutical Ltd.
- Lupin Ltd.
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“Nanotechnology-based formulations are increasingly
being explored to address some of the limitations associated with conventional
Losartan therapies, such as poor solubility, variable bioavailability, and the
need for frequent dosing. By utilizing nanocarriers such as liposomes, solid
lipid nanoparticles, and polymeric nanoparticles, researchers are developing
advanced drug delivery systems that can ensure controlled and targeted release
of Losartan at the site of action. This not only minimizes systemic side
effects but also enhances the overall pharmacological performance of the drug”,
said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Losartan Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source (Contract Manufacturing Organizations, In-House), By Application (Hypertension, Stroke, Diabetic Nephropathy, Others), By Region and Competition, 2020-2030F”, has evaluated
the future growth potential of Global Losartan Market and provides statistics
& information on market size, structure, and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Losartan Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com